![John Leonard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Leonard
Amministratore Delegato presso INTELLIA THERAPEUTICS, INC.
Patrimonio netto: 13 M $ in data 30/11/2025
Profilo
Attualmente, John M. Leonard ricopre la posizione di presidente, amministratore delegato e direttore di Intellia Therapeutics, Inc. Il dott. Leonard è anche SVP-Global Pharmaceutical Research & Development presso Abbott Laboratories e fa parte del consiglio di amministrazione di altre 6 società. Il dott. Leonard ha precedentemente occupato la posizione di Senior VP-Pharmaceuticals, Research & Development presso Abbott Laboratories, CSO, SVP-Pharmaceutical Research & Development presso AbbVie, Inc. e Senior Director-Clinical Research presso G.H. Besselaar Associates. John M. Leonard ha conseguito una laurea presso l'Università del Wisconsin e un dottorato presso la Johns Hopkins University School of Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 12/12/2025 | 1.105.900 ( 0,95% ) | 10 M $ | 30/11/2025 | |
IQVIA HOLDINGS INC 0,01% | 24/04/2025 | 15.375 ( 0,01% ) | 4 M $ | 30/11/2025 |
Ultime notizie su John Leonard
Posizioni attive di John Leonard
| Società | Posizione | Inizio |
|---|---|---|
| INTELLIA THERAPEUTICS, INC. | Amministratore Delegato | 01/01/2018 |
| IQVIA HOLDINGS INC. | Direttore/Membro del Consiglio | 05/02/2015 |
Tyree & D’Angelo Partners Management LP
 Tyree & D’Angelo Partners Management LP Tyree & D'Angelo Partners invests in lower middle market companies located in the United States and Canada with revenues less than USD 50 million and EBITDA ranging from USD 1 - 5 million. The firm focuses on companies operating in the healthcare, consumer, and business services sectors. It provides financing for buyout stage capital requirements. The firm acquires controlling stake and also makes co-investments. | Investitore di Private Equity | - |
IFM Continua, Inc.
 IFM Continua, Inc. Develops biotechnology products | Direttore/Membro del Consiglio | - |
IFM Cinque, Inc.
 IFM Cinque, Inc. Engages in research and development in biotechnology | Direttore/Membro del Consiglio | - |
IFM Quattro, Inc.
 IFM Quattro, Inc. Operates as biotechnology company | Direttore/Membro del Consiglio | - |
IFM Therapeutics LLC
 IFM Therapeutics LLC Discovers and develops small molecules that modulate novel targets in the innate immune system as next generation therapies for cancer, autoimmunity and inflammatory disorders | Direttore/Membro del Consiglio | 13/09/2018 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Direttore/Membro del Consiglio | - |
3T Biosciences, Inc.
 3T Biosciences, Inc. Operates as immunotherapy company | Direttore/Membro del Consiglio | 25/10/2022 |
Precedenti posizioni note di John Leonard
| Società | Posizione | Fine |
|---|---|---|
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di John Leonard
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 17 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | |
Chimerix, Inc.
 Chimerix, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel oral antiviral therapeutics | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Quintiles Transnational Holdings, Inc.
 Quintiles Transnational Holdings, Inc. Provides biopharmaceutical development services and commercial outsourcing services | |
AbbVie, Inc.
 AbbVie, Inc. Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vitae Pharmaceuticals LLC
 Vitae Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Focuses on discovering and developing drugs | Health Technology |
G.H. Besselaar Associates | |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Functions as a College/University | |
Tyree & D’Angelo Partners Management LP
Tyree & D’Angelo Partners Management LP Tyree & D'Angelo Partners invests in lower middle market companies located in the United States and Canada with revenues less than USD 50 million and EBITDA ranging from USD 1 - 5 million. The firm focuses on companies operating in the healthcare, consumer, and business services sectors. It provides financing for buyout stage capital requirements. The firm acquires controlling stake and also makes co-investments. | |
Intellia Therapeutics, Inc.
 Intellia Therapeutics, Inc. Develops novel and potentially curative therapeutics | |
IFM Therapeutics LLC
IFM Therapeutics LLC Discovers and develops small molecules that modulate novel targets in the innate immune system as next generation therapies for cancer, autoimmunity and inflammatory disorders | |
IQVIA Holdings, Inc.
 IQVIA Holdings, Inc. Provides outsourced clinical research and trial, mission critical information, technology, healthcare and patient engagement services | |
3T Biosciences, Inc.
3T Biosciences, Inc. Operates as immunotherapy company | |
IFM Cinque, Inc.
IFM Cinque, Inc. Engages in research and development in biotechnology | |
IFM Continua, Inc.
IFM Continua, Inc. Develops biotechnology products | |
IFM Quattro, Inc.
IFM Quattro, Inc. Operates as biotechnology company |
